small molecule modulator

A unique collection of 718 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).

A unique collection of 924 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs;

A unique collection of 941 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and cancer;

Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system's ability to readily detoxify the reactive intermediates or repair the resulting damage. Disturbances in the normal redox state of cells can cause toxic effects through the production of peroxides and free radicals that damage all components of the cell, including proteins, lipids, and DNA. In humans, oxidative stress is thought to be involved in the development of atherosclerosis, heart failure, myocardial infarction, cancer, infection etc. Antioxidants are a class of compounds that counteract oxidative stress and reduce oxidative damage. The TargetMol Antioxidant Compound Library is a unique collection of 2010 small molecules with inhibitory effects on oxidative stress and is a useful tool for high-throughput screening and high-content screening in the study of oxidative stress.

A unique collection of 700 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1120 compounds targeting NF-κB signaling for high throughput screening and high content screening;

A unique collection of 210 TGF-beta/Smad signaling targeted compounds for high throughput and high content screening;

A unique collection of 530 Wnt/Hedgehog/Notch signaling targeted compounds for high throughput and high content screening;

A unique collection of 300 calcium channel blockers and agonists for high throughput and high content screening;

A unique collection of 215 sodium channel blockers and agonists for high throughput and high content screening;

A unique collection of 950 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study;

A unique collection of 2394 apoptosis-related compounds for apoptosis research, research in tumorigenesis, and anti-cancer drug screening;

A unique collection of 223 endoplasmic reticulum stress (ER stress) related compounds used for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 3000 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;

A unique collection of 1220 compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery;

A unique collection of 280 bioactive compounds specifically targeting adrenergic receptors, effective tool for screening new drugs or new target identification;